SCHEMBL15401987

SCHEMBL15401987

Cn1cc(C(N)=O)c(C(=O)NCCO)n1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HSD17B10 Q99714 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.40
PDE10A Q9Y233 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
IRAK4 Q9NWZ3 3/20 0.38
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
CNR2 P34972 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CCNA1 P78396 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17966580 0.87 L3MBTL1 (0.41) L3MBTL1KDM4ESMN1; SMN2LMNAIRAK4
SCHEMBL17966593 0.84 GAA (0.40) L3MBTL1KDM4ESMN1; SMN2LMNAIRAK4
SCHEMBL15401989 0.83 L3MBTL1 (0.46) TP53L3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL17966485 0.83 SMN1; SMN2 (0.39) L3MBTL1KDM4ESMN1; SMN2LMNAIRAK4
SCHEMBL17966529 0.83 KDM4E (0.42) L3MBTL1KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL17966565 0.82 KDM4E (0.39) L3MBTL1KDM4ESMN1; SMN2IRAK4GAA
SCHEMBL17966504 0.82 KDM4E (0.39) L3MBTL1KDM4ESMN1; SMN2IRAK4GAA
SCHEMBL17966551 0.81 JAK2 (0.39) L3MBTL1KDM4ESMN1; SMN2LMNAIRAK4
SCHEMBL7515585 0.81 GAA (0.44) L3MBTL1SMN1; SMN2LMNAIRAK4GAA
SCHEMBL15402378 0.80 PDE10A (0.43) L3MBTL1SMN1; SMN2LMNAPDE10AIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A TP53 4670/4885L3MBTL1 3429/4885KDM4E 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.